BIO-TECHNE Corp Cash and Cash Equivalents, Period Increase (Decrease)
BIO-TECHNE Corp (TECH) reported Cash and Cash Equivalents, Period Increase (Decrease) of $55.33 million for the 9-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-05-11
- BIO-TECHNE Corp cash and cash equivalents, period increase (decrease) for the quarter ending 2020-03-31 was $45.92M, a 374.67% increase year-over-year.
- BIO-TECHNE Corp cash and cash equivalents, period increase (decrease) for the quarter ending 2019-12-31 was $10.40M.
- BIO-TECHNE Corp cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was -$995.00K.
- BIO-TECHNE Corp cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was $5.33M, a 84.95% decline year-over-year.
- BIO-TECHNE Corp cash and cash equivalents, period increase (decrease) for fiscal 2019 was -$21.10M, a 169.47% decline from fiscal 2018.
- BIO-TECHNE Corp cash and cash equivalents, period increase (decrease) for fiscal 2018 was $30.38M, a 10.97% increase from fiscal 2017.
- BIO-TECHNE Corp cash and cash equivalents, period increase (decrease) for fiscal 2017 was $27.38M, a 182.07% increase from fiscal 2016.
- BIO-TECHNE Corp cash and cash equivalents, period increase (decrease) for fiscal 2016 was $9.71M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2020-03-31 | $45.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | $56.33M derived: sum of 2 quarters · filed 2020-05-11 | $55.33M 10-Q · filed 2020-05-11 | $60.66M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | $10.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | $9.41M 10-Q · filed 2020-02-06 | $14.73M derived: sum of 3 quarters · filed 2020-02-06 | $24.41M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-09-30 | -$995.00K 10-Q · filed 2019-11-06 | $4.33M derived: sum of 2 quarters · filed 2019-11-06 | $14.01M derived: sum of 3 quarters · filed 2020-05-11 | $5.22M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-06-30 | $5.33M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | $15.00M derived: sum of 2 quarters · filed 2020-05-11 | $6.21M derived: sum of 3 quarters · filed 2020-05-11 | -$21.10M 10-K/A · filed 2019-11-06 |
| 2019-03-31 | $9.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | $887.00K derived: sum of 2 quarters · filed 2020-05-11 | -$26.43M 10-Q · filed 2020-05-11 | $8.95M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$8.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | -$36.10M 10-Q · filed 2020-02-06 | -$722.00K derived: sum of 3 quarters · filed 2020-02-06 | -$35.57M derived: sum of 4 quarters · filed 2020-02-06 |
| 2018-09-30 | -$27.32M 10-Q · filed 2019-11-06 | $8.07M derived: sum of 2 quarters · filed 2019-11-06 | -$26.78M derived: sum of 3 quarters · filed 2019-11-06 | $22.21M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | $35.38M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | $532.00K derived: sum of 2 quarters · filed 2019-11-06 | $49.53M derived: sum of 3 quarters · filed 2019-11-06 | $30.38M 10-K/A · filed 2019-11-06 |
| 2018-03-31 | -$34.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-07 | $14.14M derived: sum of 2 quarters · filed 2019-05-07 | -$5.00M 10-Q · filed 2019-05-07 | $26.77M derived: sum of 4 quarters · filed 2019-11-06 |
| 2017-12-31 | $48.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07 | $29.85M 10-Q · filed 2019-02-07 | $61.62M derived: sum of 3 quarters · filed 2019-11-06 | $62.52M derived: sum of 4 quarters · filed 2019-11-06 |
| 2017-09-30 | -$19.15M 10-Q · filed 2018-11-07 | $12.62M derived: sum of 2 quarters · filed 2019-11-06 | -$19.15M 10-Q · filed 2017-11-09 | $2.88M derived: sum of 4 quarters · filed 2019-11-06 |
| 2017-06-30 | $31.77M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | $32.68M derived: sum of 2 quarters · filed 2019-11-06 | $22.02M derived: sum of 3 quarters · filed 2019-11-06 | $27.38M 10-K/A · filed 2019-11-06 |
| 2017-03-31 | $904.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | -$9.75M derived: sum of 2 quarters · filed 2018-05-09 | -$4.40M 10-Q · filed 2018-05-09 | -$5.87M derived: sum of 4 quarters · filed 2018-08-27 |
| 2016-12-31 | -$10.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | -$5.30M 10-Q · filed 2018-02-08 | -$6.78M derived: sum of 3 quarters · filed 2018-08-27 | -$3.52M derived: sum of 4 quarters · filed 2018-08-27 |
| 2016-09-30 | $5.35M 10-Q · filed 2016-11-09 | $3.88M derived: sum of 2 quarters · filed 2018-08-27 | $5.35M 10-Q · filed 2017-11-09 | $20.75M derived: sum of 4 quarters · filed 2018-08-27 |
| 2016-06-30 | -$1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-27 | $1.78M derived: sum of 2 quarters · filed 2018-08-27 | $15.39M derived: sum of 3 quarters · filed 2018-08-27 | $9.71M 10-K · filed 2018-08-27 |
| 2016-03-31 | $3.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-10 | $16.87M derived: sum of 2 quarters · filed 2017-05-10 | $11.18M 10-Q · filed 2017-05-10 | -$40.73M derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-12-31 | $13.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | $7.92M 10-Q · filed 2017-02-09 | -$43.99M derived: sum of 3 quarters · filed 2017-09-07 | -$30.52M derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-09-30 | -$5.69M 10-Q · filed 2016-11-09 | -$57.60M derived: sum of 2 quarters · filed 2017-09-07 | -$44.13M derived: sum of 3 quarters · filed 2017-09-07 | -$49.40M derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-06-30 | -$51.91M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | -$38.44M derived: sum of 2 quarters · filed 2017-09-07 | -$43.71M derived: sum of 3 quarters · filed 2017-09-07 | -$264.04M 10-K · filed 2017-09-07 |
| 2015-03-31 | $13.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | $8.21M derived: sum of 2 quarters · filed 2016-05-10 | -$212.12M 10-Q · filed 2016-05-10 | -$17.16M derived: sum of 4 quarters · filed 2016-08-29 |
| 2014-12-31 | -$5.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09 | -$225.60M 10-Q · filed 2016-02-09 | -$30.64M derived: sum of 3 quarters · filed 2016-08-29 | -$5.43M derived: sum of 4 quarters · filed 2016-08-29 |
| 2014-09-30 | -$220.33M 10-Q · filed 2015-11-09 | -$25.36M derived: sum of 2 quarters · filed 2016-08-29 | -$163.00K derived: sum of 3 quarters · filed 2016-08-29 | $14.38M derived: sum of 4 quarters · filed 2016-08-29 |
| 2014-06-30 | $194.97M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29 | $220.17M derived: sum of 2 quarters · filed 2016-08-29 | $234.71M derived: sum of 3 quarters · filed 2016-08-29 | $154.78M 10-K · filed 2016-08-29 |
| 2014-03-31 | $25.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-11 | $39.75M derived: sum of 2 quarters · filed 2015-05-11 | -$40.18M 10-Q · filed 2015-05-11 | -$27.11M derived: sum of 4 quarters · filed 2015-08-31 |
| 2013-12-31 | $14.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-09 | -$65.38M 10-Q · filed 2015-02-09 | -$52.31M derived: sum of 3 quarters · filed 2015-08-31 | -$44.88M derived: sum of 4 quarters · filed 2015-08-31 |
| 2013-09-30 | -$79.93M 10-Q · filed 2014-11-10 | -$66.86M derived: sum of 2 quarters · filed 2015-08-31 | -$59.43M derived: sum of 3 quarters · filed 2015-08-31 | -$46.95M derived: sum of 4 quarters · filed 2015-08-31 |
| 2013-06-30 | $13.07M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31 | $20.50M derived: sum of 2 quarters · filed 2015-08-31 | $32.98M derived: sum of 3 quarters · filed 2015-08-31 | $47.11M 10-K · filed 2015-08-31 |
| 2013-03-31 | $7.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12 | $19.91M derived: sum of 2 quarters · filed 2014-05-12 | $34.04M 10-Q · filed 2014-05-12 | $55.43M derived: sum of 4 quarters · filed 2014-08-29 |
| 2012-12-31 | $12.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-04 | $26.61M 10-Q · filed 2014-02-04 | $48.01M derived: sum of 3 quarters · filed 2014-08-29 | $62.29M derived: sum of 4 quarters · filed 2014-08-29 |
| 2012-09-30 | $14.13M 10-Q · filed 2013-11-12 | $35.52M derived: sum of 2 quarters · filed 2014-08-29 | $49.81M derived: sum of 3 quarters · filed 2014-08-29 | $51.57M derived: sum of 4 quarters · filed 2014-08-29 |
| 2012-06-30 | $21.39M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-29 | $35.68M derived: sum of 2 quarters · filed 2014-08-29 | $37.44M derived: sum of 3 quarters · filed 2014-08-29 | $39.06M 10-K · filed 2014-08-29 |
| 2012-03-31 | $14.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-10 | $16.05M derived: sum of 2 quarters · filed 2013-05-10 | $17.67M 10-Q · filed 2013-05-10 | -$63.35M derived: sum of 4 quarters · filed 2013-08-29 |
| 2011-12-31 | $1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-11 | $3.38M 10-Q · filed 2013-02-11 | -$77.63M derived: sum of 3 quarters · filed 2013-08-29 | -$54.88M derived: sum of 4 quarters · filed 2013-08-29 |
| 2011-09-30 | $1.62M 10-Q · filed 2012-11-09 | -$79.39M derived: sum of 2 quarters · filed 2013-08-29 | -$56.64M derived: sum of 3 quarters · filed 2013-08-29 | -$35.78M derived: sum of 4 quarters · filed 2013-08-29 |
| 2011-06-30 | -$81.02M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29 | -$58.26M derived: sum of 2 quarters · filed 2013-08-29 | -$37.40M derived: sum of 3 quarters · filed 2013-08-29 | -$16.53M 10-K · filed 2013-08-29 |
| 2011-03-31 | $22.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-10 | $43.62M derived: sum of 2 quarters · filed 2012-05-10 | $64.49M 10-Q · filed 2012-05-10 | $50.39M derived: sum of 4 quarters · filed 2012-08-29 |
| 2010-12-31 | $20.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-07 | $41.74M 10-Q · filed 2012-02-07 | $27.64M derived: sum of 3 quarters · filed 2012-08-29 | -$59.68M derived: sum of 4 quarters · filed 2012-08-29 |
| 2010-09-30 | $20.87M 10-Q · filed 2011-11-09 | $6.78M derived: sum of 2 quarters · filed 2012-08-29 | -$80.54M derived: sum of 3 quarters · filed 2012-08-29 | -$59.74M derived: sum of 4 quarters · filed 2012-08-29 |
| 2010-06-30 | -$14.10M derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-29 | -$101.41M derived: sum of 2 quarters · filed 2012-08-29 | -$80.62M derived: sum of 3 quarters · filed 2012-08-29 | -$66.80M 10-K · filed 2012-08-29 |
| 2010-03-31 | -$87.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-05-10 | -$66.52M derived: sum of 2 quarters · filed 2011-05-10 | -$52.70M 10-Q · filed 2011-05-10 | |
| 2009-12-31 | $20.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-02-09 | $34.61M 10-Q · filed 2011-02-09 | ||
| 2009-09-30 | $13.82M 10-Q · filed 2010-11-09 | |||
| 2009-06-30 | -$6.05M 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |